|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.00 CZK | -0.41% |
|
-2.02% | -28.82% |
| 06-14 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-04-25 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Revenues | 2.38B | 2.45B | 2.13B | 1.3B | 876M |
Total Revenues | 2.38B | 2.45B | 2.13B | 1.3B | 876M |
Cost of Goods Sold, Total | 2.37B | 2.45B | 1.83B | 1.12B | 746M |
Gross Profit | 13.52M | 273K | 297M | 183M | 131M |
Selling General & Admin Expenses, Total | - | - | 364M | 229M | 181M |
Depreciation & Amortization - (IS) | - | - | 73.94M | 72.91M | 28.29M |
Amortization of Goodwill and Intangible Assets - (IS) | 12.1M | 2.29M | - | - | - |
Other Operating Expenses | 15.4M | 45.66M | 7.51M | -8.69M | -61.94M |
Other Operating Expenses, Total | 27.5M | 47.95M | 446M | 293M | 147M |
Operating Income | -13.99M | -47.67M | -149M | -110M | -16.48M |
Interest Expense, Total | -777K | -4.76M | -10.48M | -12.33M | -16.98M |
Interest And Investment Income | 714K | 206K | 49K | 6K | 6K |
Net Interest Expenses | -63K | -4.56M | -10.43M | -12.33M | -16.97M |
Other Non Operating Income (Expenses) | -10.63M | -11.78M | -16.88M | -12.68M | -6.78M |
EBT, Excl. Unusual Items | -24.68M | -64.01M | -176M | -135M | -40.23M |
Gain (Loss) On Sale Of Assets | - | - | 19K | 8.56M | 1.72M |
EBT, Incl. Unusual Items | -24.68M | -64.01M | -176M | -126M | -38.51M |
Income Tax Expense | 994K | 1.75M | 4K | - | 107K |
Earnings From Continuing Operations | -25.67M | -65.76M | -176M | -126M | -38.62M |
Net Income to Company | -25.67M | -65.76M | -176M | -126M | -38.62M |
Minority Interest | 175K | 820K | 932K | 635K | -251K |
Net Income - (IS) | -25.5M | -64.94M | -175M | -126M | -38.87M |
Net Income to Common Incl Extra Items | -25.5M | -64.94M | -175M | -126M | -38.87M |
Net Income to Common Excl. Extra Items | -25.5M | -64.94M | -175M | -126M | -38.87M |
Per Share Items | |||||
Net EPS - Basic | - | -25.76 | -64.63 | -46.46 | - |
Basic EPS - Continuing Operations | - | -25.76 | -64.63 | -46.46 | - |
Basic Weighted Average Shares Outstanding | - | 2.52M | 2.71M | 2.71M | - |
Net EPS - Diluted | - | -25.76 | -64.63 | -46.46 | - |
Diluted EPS - Continuing Operations | - | -25.76 | -64.63 | -46.46 | - |
Diluted Weighted Average Shares Outstanding | - | 2.52M | 2.71M | 2.71M | - |
Normalized Basic EPS | - | -15.54 | -40.27 | -30.92 | - |
Normalized Diluted EPS | - | -15.54 | -40.27 | -30.92 | - |
Supplemental Items | |||||
EBITDA | 8.33M | -29.82M | -126M | -90.27M | 17.8M |
EBITA | -962K | -44.49M | -146M | -108M | -16.48M |
EBIT | -13.99M | -47.67M | -149M | -110M | -16.48M |
Effective Tax Rate - (Ratio) | -4.03 | -2.73 | -0 | - | -0.28 |
Total Current Taxes | 871K | -1K | - | - | - |
Total Deferred Taxes | 123K | 1.75M | 4K | - | - |
Normalized Net Income | -15.25M | -39.19M | -109M | -83.7M | -25.4M |
- Stock Market
- Stocks
- PINK Stock
- Financials Pilulka Lékárny
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















